ARCHIVES

Panel Resumes Deliberations

This article is from The Cancer Letter archive.

Vol. 06 No. 01 | January 4, 1980

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Recompetition Of Two Major Contracts

October 30, 1987

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014

October issue of Business & Regulatory Report included.

November 5, 2004

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

November 25, 2011